Navigation Links
Symmetry Medical to Host Investor Breakfast on February 17, 2011
Date:2/8/2011

WARSAW, Ind., Feb. 8, 2011 /PRNewswire/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that the Company will host an Investor Breakfast on Thursday, February 17, 2011 at 7:30 a.m. PT.  Tom Sullivan, President & Chief Executive Officer; Brian Moore, President of Business Development; and Fred Hite, Senior Vice President & Chief Financial Officer, will host the event.

The Investor Breakfast is being held in conjunction with the American Association of Orthopedic Surgeons (AAOS) Annual Meeting in San Diego, CA.  A live Web cast of the Investor Breakfast will be available online from the investor relations page of the Company's corporate Web site at www.symmetrymedical.com.  After the live Web cast, a replay will remain available on Symmetry Medical's Web site through March 17, 2011.

About Symmetry Medical Inc.Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Forward-Looking StatementsStatements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at www.sec.gov.Contact:

Symmetry Medical Inc.

Fred L. Hite

Senior Vice President

Chief Financial Officer

(574) 371-2218Investors:

The Ruth Group

Nick Laudico/Zack Kubow

(646) 536-7030/7020

nlaudico@theruthgroup.com

zkubow@theruthgroup.comMedia:

Jason Rando

The Ruth Group

(646) 536-7025

jrando@theruthgroup.com
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer
2. Symmetry Medical Closes $200 Million Credit Facility
3. Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010
4. Symmetry Medical to Present at Two Upcoming Conferences
5. Symmetry Medical Announces Restructuring
6. Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
7. Symmetry Medical Reports Third Quarter 2009 Financial Results
8. Symmetry Medical Updates Full Year 2009 Financial Guidance
9. Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009
10. UBM TechInsights Issues Warning to Medical Devices Industry About Possible Obsolescence as Reliance on Smartphones Increases
11. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):